Comment on "Preclinical assessment of histone deacetylase inhibitor quisinostat as a therapeutic agent against esophageal squamous cell carcinoma"

Lin, J

Lin, J (corresponding author), Guangdong Med Univ, Affiliated Hosp, Dept Oncol, 27 South Ren Min Rd, Zhanjiang 524200, Guangdong, Peoples R China.

INVESTIGATIONAL NEW DRUGS, 2021; 39 (5): 1454

Abstract

Recently, we read a paper "Preclinical assessment of histone deacetylase inhibitor quisinostat as a therapeutic agent against esophageal squamous cell......

Full Text Link